Last update 08 May 2025

SMRX-11

Overview

Basic Info

Drug Type
Fusion protein
Synonyms
CSSK, Clot-buster protein, Clot-specific streptokinase
+ [2]
Target
PLG
Action
stimulants
Mechanism
PLG stimulants(Plasminogen stimulants)
Therapeutic Areas
Other Diseases
Active Indication
Hemorrhage
Inactive Indication
Myocardial InfarctionThrombosis
Originator Organization
Institute of Microbial TechnologyInstitute of Microbial Technology
Active Organization
Nostrum Pharmaceuticals LLCNostrum Pharmaceuticals LLC
Inactive Organization
Institute of Microbial TechnologyInstitute of Microbial TechnologyNostrumNostrum
License Organization-
Drug Highest PhaseClinical
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Related

1
Clinical Trials associated with SMRX-11
CTRI/2014/03/004442
/ RecruitingPhase 1/2
Efficacy and Safety of Bolus Injection of a Novel Thrombolytic Agent (SMRX-11) in Patients with Acute ST-segment Elevation Myocardial Infarction (STEMI): A Phase II Open-Label, Dose-Escalation, Multicentre, Angiographic Trial - SMRX-11
100 Clinical Results associated with SMRX-11
Login to view more data
100 Translational Medicine associated with SMRX-11
Login to view more data
100 Patents (Medical) associated with SMRX-11
Login to view more data
1
Literatures (Medical) associated with SMRX-11
16 Mar 2000Report on medical guidelines & outcomes research
Clot-buster proves safe, effective when given during first three hours after a stroke.
100 Deals associated with SMRX-11
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
ThrombosisPreclinical
India
Nostrum Pharmaceuticals LLCNostrum Pharmaceuticals LLC
-
Myocardial InfarctionDiscovery-
Institute of Microbial TechnologyInstitute of Microbial Technology
-
Myocardial InfarctionDiscovery-
NostrumNostrum
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free